Table 2:

Percentage correct with the model when applied to the discovery cohort and validation cohort

Medulloblastoma SubgroupsPercentage Correct in Discovery CohortPercentage Correct in Validation Cohort
Total66%65%
    WNT75%50%
    SHH54%73%
    Group 392%83%
    Group 459%58%